Leaflet SUNITINIB G.L PHARMA 25mg capsules
Indicated for: gastrointestinal stromal tumors
Route of administration: oral
Substance: sunitinib (tyrosine kinase inhibitor)
ATC: L01EX01 (Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors)
This medicine may affect fertility.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
Avoid grapefruit and grapefruit juice.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
This medicine may increase the risk of heart rhythm disturbances.
Sunitinib is a tyrosine kinase inhibitor used in the treatment of certain types of cancer, such as renal cell carcinoma and gastrointestinal stromal tumors. It works by blocking receptors involved in the growth and spread of tumor cells.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular medical check-ups to monitor the response to treatment.
Patients should be aware of potential side effects, such as fatigue, nausea, or high blood pressure. It is important to inform the doctor of any unusual symptoms.
Common side effects include fatigue, nausea, diarrhea, and changes in blood pressure. In rare cases, severe reactions such as heart failure or tumor lysis syndrome may occur. Patients should be informed of these risks before starting treatment.
General data about SUNITINIB G.L PHARMA 25mg
- Substance: sunitinib
- Date of last drug list: 01-06-2026
- Commercial code: W67790002
- Concentration: 25mg
- Pharmaceutical form: capsules
- Quantity: 30
- Product type: generic
- Price: 1356.45 RON
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Concentrations available for sunitinib
- 12.5mg
- 25mg
- 37.5mg
- 50mg